基本信息
浏览量:2
职业迁徙
个人简介
Sally Barrington trained in Nuclear Medicine at Guy’s and St Thomas’ Hospitals and was appointed as Consultant in Nuclear Medicine in 1998. Her clinical experience encompasses all aspects of PET-CT including oncology, neurology, cardiology and infection/inflammation using a variety of tracers. She is co-lead of the UK PET Research Network with Prof Paul Marsden based at the KCL and GSTT PET Imaging Centre at St Thomas'. Research interests - PET and lymphoma - Standardisation of PET and organisation of multicentre trials - PET and Radiotherapy planning Dr Barrington is the author of: International guidelines on the staging and response assessment of lymphoma European guidelines on the use of FDG in Tumour Imaging European and UK guidelines on the use of PET-CT in Children British Society of Haematology guidelines in Hodgkin and Diffuse Large B Cell Lymphoma She is involved in national and international multicentre trials in PET and lymphoma investigating response-adapted approaches and is a central reviewer for the following trials: PETReA - Phase 3 evaluation of PET-guided, Response-Adapted therapy in patients with previously untreated, high tumour burden follicular lymphoma IELSG 37 - A randomised, open-label, multicentre, two-arm phase III comparative study assessing the role of involved mediastinal radiotherapy after rituximab containing chemotherapy regimens to patients with newly diagnosed primary mediastinal B-Cell lymphoma (PMBL) (International) BREVITY: A phase II study of brentuximab vedotin (SGN-35) using a response adapted design in patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity (UK) TORCH: Dual mTOR inhibition and PET based response in DLBCL – exploratory analysis within the TORCH phase II trial (UK) CARDAMON: Carfilzomib/Cyclophosphamide/Dexamethasone with maintenance carfilzomib in untreated transplant-eligible patients with symptomatic multiple myeloma to evaluate the benefit of upfront autologous stem cell transplant Other activities: Member of the Scientific Committee for international workshops on PET in lymphoma, European Lymphoma Institute (2010-current) Lecturer on European Society of Oncology Programme awarding the Certificate of Competence in lymphoma (2012-current) Editorial Board of Journal of Clinical Oncology (2013-current) Member of Administration of Radioactive Substances Advisory Committee (ARSAC) (2012- current) Member of CRUK Expert Review Panel Chair of the Radiation Safety Committee of Guy's and St Thomas' NHS Foundation Trust (2013-current) Member of Oncology Committee of the European Association of Nuclear Medicine (2013-2017) Grant collaborations beyond King's College London: A Pettitt SF Barrington et al. CRUK/16/017 PETReA: Phase 3 evaluation of PET-guided, Response-Adapted therapy in patients with previously untreated, high tumour burden follicular lymphoma (PETReA) reference C18029/A21585 01/10/2016 - duration 98 months: £1,482,852.67 G Collins, SF Barrington et al Dual mTOR inhibition and PET based response in DLBCL – exploratory analysis within the TORCH phase II trial Leukaemia and Lymphoma Research 14029 (2015): £44,100 A Davies, SF Barrington et al CRUK/12/040: IELSG 37 - A randomised, open-label, multicentre, two-arm phase III comparative study assessing the role of involved mediastinal radiotherapy after rituximab containing chemotherapy regimens to patients with newly diagnosed primary mediastinal B-Cell lymphoma (PMBL) 01 May 2013 to 30 April 2022 CTAAC : C30423/A16247 £247,533 J Radford, SF Barrington et al ""BREVITY: A phase II study of brentuximab vedotin (SGN-35) using a response adapted design in patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity"" (2012) Millenium £330,673
研究兴趣
论文共 68 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Graham Mcilroy, Sian Lax,Charlotte Gaskell,Aimee Jackson, Malcolm Rhodes, Tania Seale,Sonia Fox, Lousie Hopkins,Jessica Okosun,Sally F. Barrington, Ingo Ringshausen,Alan G. Ramsay,
BMC CANCERno. 1 (2024)
Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2024)
Sally Barrington,Barbara Fischer,Amy A. Kirkwood,Diederik J. Grootendorst, Aytekin Akyol, Steven M. Ansell,Philippe Armand, L. H. Schwartz
Hematological Oncologyno. S2 (2023): 92-93
引用0浏览0引用
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 17 (2023)
引用0浏览0引用
0
0
Hematological oncologyno. S1 (2023): 11-19
引用0浏览0WOS引用
0
0
Venkatraman Radhakrishnan,Louise Stanton,Josh Caddy, Nicole Keyworth,Geoff Saunders,Sharon Barrans, Jane Rafferty, Trish Joyce,Graham P. Collins,Sally Barrington,Victoria Warbey, Christopher P. Fox,
Hematological Oncologyno. S2 (2023): 166-167
引用0浏览0引用
0
0
PLOS ONEno. 3 (2023): e0283694-e0283694
Journal of nuclear medicine : official publication, Society of Nuclear Medicineno. 1 (2022): 102-108
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn